• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Building the infrastructure to make science metrics more scientific.

作者信息

Lin Jennifer, Murphy Fiona L, Taylor Mike, Allen Liz

机构信息

Department of Product Development, Crossref, Oxford, UK.

Associate Fellow, Institute for Environmental Analytics, University of Reading, Reading, UK.

出版信息

F1000Res. 2016 Dec 21;5:2897. doi: 10.12688/f1000research.10422.2. eCollection 2016.

DOI:10.12688/f1000research.10422.2
PMID:28503295
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5405792/
Abstract

Research leaders, policy makers and science strategists need evidence to support decision-making around research funding investment, policy and strategy.  In recent years there has been a rapid expansion in the data sources available that shed light onto aspects of research quality, excellence, use, re-use and attention, and engagement. This is at a time when the modes and routes to share and communicate research findings and data are also changing.  In this opinion piece, we outline a series of considerations and interventions that are needed to ensure that research metric development is accompanied by appropriate scrutiny and governance, to properly support the needs of research assessors and decision-makers, while securing the confidence of the research community. Key among these are: agreed 'gold standards' around datasets and methodologies; full transparency around the calculation and derivation of research-related indicators; and a strategy and roadmap to take the discipline of scientific indicators and research assessment to a more robust and sustainable place.

摘要

相似文献

1
Building the infrastructure to make science metrics more scientific.
F1000Res. 2016 Dec 21;5:2897. doi: 10.12688/f1000research.10422.2. eCollection 2016.
2
Procedures and methods of benefit assessments for medicines in Germany.德国药品效益评估的程序和方法。
Eur J Health Econ. 2008 Nov;9 Suppl 1:5-29. doi: 10.1007/s10198-008-0122-5.
3
[Procedures and methods of benefit assessments for medicines in Germany].[德国药品效益评估的程序和方法]
Dtsch Med Wochenschr. 2008 Dec;133 Suppl 7:S225-46. doi: 10.1055/s-0028-1100954. Epub 2008 Nov 25.
4
Implementing and using quality measures for children's health care: perspectives on the state of the practice.实施和使用儿童保健质量指标:实践现状透视
Pediatrics. 2004 Jan;113(1 Pt 2):217-27.
5
Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy.实用临床试验:提高临床研究在临床和卫生政策决策中的价值。
JAMA. 2003 Sep 24;290(12):1624-32. doi: 10.1001/jama.290.12.1624.
6
A research roadmap for complementary and alternative medicine - what we need to know by 2020.补充和替代医学研究路线图——到2020年我们需要了解的内容。
Forsch Komplementmed. 2014;21(2):e1-16. doi: 10.1159/000360744. Epub 2014 Mar 24.
7
Evidence-Based Policy Making: Assessment of the American Heart Association's Strategic Policy Portfolio: A Policy Statement From the American Heart Association.循证决策:美国心脏协会战略政策组合评估:美国心脏协会政策声明
Circulation. 2016 May 3;133(18):e615-53. doi: 10.1161/CIR.0000000000000410. Epub 2016 Apr 4.
8
Identifying ELIXIR Core Data Resources.识别ELIXIR核心数据资源。
F1000Res. 2016 Sep 30;5. doi: 10.12688/f1000research.9656.2. eCollection 2016.
9
[Memorandum on sustainable reinforcement of prevention and health promotion: challenges at the federal, state and local level].[关于可持续加强预防与健康促进的备忘录:联邦、州和地方层面的挑战]
Gesundheitswesen. 2015 May;77(5):382-8. doi: 10.1055/s-0035-1549949. Epub 2015 May 27.
10
American Society of Clinical Oncology policy statement: oversight of clinical research.美国临床肿瘤学会政策声明:临床研究监督
J Clin Oncol. 2003 Jun 15;21(12):2377-86. doi: 10.1200/JCO.2003.04.026. Epub 2003 Apr 29.